Louisiana State Employees Retirement System Sells 1,100 Shares of CVS Health Corporation $CVS

Louisiana State Employees Retirement System decreased its position in CVS Health Corporation (NYSE:CVS) by 1.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 66,700 shares of the pharmacy operator’s stock after selling 1,100 shares during the quarter. Louisiana State Employees Retirement System’s holdings in CVS Health were worth $4,601,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of CVS. Bell Investment Advisors Inc increased its holdings in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC increased its holdings in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC increased its holdings in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares in the last quarter. Saudi Central Bank bought a new position in shares of CVS Health during the first quarter valued at $34,000. Finally, Livelsberger Financial Advisory bought a new position in shares of CVS Health during the second quarter valued at $35,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Trading Down 0.2%

Shares of NYSE:CVS opened at $76.94 on Thursday. The stock has a market capitalization of $97.59 billion, a price-to-earnings ratio of 21.49, a PEG ratio of 0.85 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The stock’s 50-day simple moving average is $71.68 and its two-hundred day simple moving average is $67.52. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $79.20.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $98.92 billion for the quarter, compared to analysts’ expectations of $94.87 billion. During the same period last year, the firm posted $1.83 earnings per share. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s payout ratio is presently 74.30%.

Wall Street Analyst Weigh In

CVS has been the subject of several analyst reports. Wells Fargo & Company raised their price target on CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday. Bernstein Bank dropped their price objective on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research report on Wednesday, July 16th. UBS Group raised CVS Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Cowen reaffirmed a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Finally, Wolfe Research increased their price objective on CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Monday, September 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.20.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.